What is sglt 2
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 1, 2026
Key Facts
- SGLT2 inhibitors work by preventing glucose reabsorption in the kidneys, allowing excess glucose to be excreted through urine
- These medications benefit both type 1 and type 2 diabetes patients and offer cardiovascular protective effects
- SGLT2 inhibitors also reduce body weight and blood pressure, providing benefits beyond blood sugar control
- Common SGLT2 inhibitor medications include empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana)
- SGLT2 inhibitors have demonstrated protective effects on kidney function and reduced risk of heart failure
Understanding SGLT2 and Kidney Function
SGLT2 (Sodium-Glucose Cotransporter-2) is a protein located in the cells of the kidney's proximal tubule. Under normal conditions, when blood glucose levels are high, the kidneys filter glucose but then reabsorb it back into the bloodstream through SGLT2 transporters. This reabsorption prevents glucose from being wasted in urine, which is normally a healthy function. However, in people with diabetes, this reabsorption can maintain dangerously high blood glucose levels.
How SGLT2 Inhibitors Work
SGLT2 inhibitor medications block the SGLT2 transporter, preventing the kidney from reabsorbing glucose. This forces excess glucose to be excreted in the urine instead of being returned to the bloodstream. The result is lower blood glucose levels achieved through a different mechanism than other diabetes drugs. Rather than increasing insulin production or improving insulin sensitivity, SGLT2 inhibitors work by removing glucose from the body entirely.
Benefits Beyond Blood Sugar Control
Research has shown that SGLT2 inhibitors provide benefits beyond lowering blood glucose:
- Weight loss: Glucose excretion in urine represents lost calories, contributing to modest weight reduction
- Blood pressure reduction: These medications reduce blood pressure through diuretic effects and improved vascular function
- Heart protection: SGLT2 inhibitors reduce the risk of heart attacks and heart failure, even in non-diabetic patients
- Kidney protection: They slow the progression of kidney disease, a major complication of diabetes
Common SGLT2 Inhibitor Medications
Several SGLT2 inhibitors are available by prescription, each with slightly different characteristics and FDA approvals. Empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana) are among the most commonly prescribed. These medications are typically taken as oral tablets once or twice daily.
Considerations and Side Effects
SGLT2 inhibitors are generally well-tolerated but can cause genital infections due to increased glucose in urine. Rare but serious side effects include diabetic ketoacidosis and urinary tract infections. They're typically used alongside other diabetes medications and require regular monitoring of kidney function and blood glucose levels.
Related Questions
What are the side effects of SGLT2 inhibitors?
Common side effects include urinary tract infections and genital yeast infections due to increased glucose in urine. Rare but serious side effects can include diabetic ketoacidosis. Most patients tolerate these medications well, but kidney function and blood glucose should be monitored regularly.
How do SGLT2 inhibitors compare to other diabetes medications?
SGLT2 inhibitors work differently than metformin, sulfonylureas, or GLP-1 agonists. While other drugs improve insulin production or sensitivity, SGLT2 inhibitors remove glucose through the kidneys. They're often used in combination with other medications for improved blood sugar control.
Can SGLT2 inhibitors help with weight loss?
Yes, SGLT2 inhibitors can contribute to modest weight loss (typically 2-3 kg) by causing glucose to be excreted in urine, which represents lost calories. This weight loss occurs independent of improved blood sugar control and is an additional benefit of these medications.
More What Is in Daily Life
Also in Daily Life
More "What Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- FDA - SGLT2 Inhibitor Drug ApprovalsPublic Domain
- Wikipedia - SGLT2 InhibitorCC-BY-SA-4.0
Missing an answer?
Suggest a question and we'll generate an answer for it.